With NHS England highlighting savings of £1.2 billion on medicines in three years coming from both deals on generics and new innovative treatments, Leela Barham takes stock of what we know
The former chair of NHS Digital has slammed the decision to absorb the unit into NHS England as a "significant retrograde step" that could undermine citizens' rights over their health data.
It has been confirmed that NHS Digital and NHSX are to be incorporated into NHS England as part of a major shake-up of the health technology environment.
The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio